Skip to main content
  • Nederlands
    • English
    • Français

Home
  • Inloggen
  • Therapeutische domeinen
    • Cardiologie
      • ASCVD
    • Dermatologie
      • Netelroos
    • Hematologie
      • ITP
    • Luchtwegen
    • Neurologie
      • Multiple sclerose
    • Oncologie
      • Borstkanker
      • Prostate Cancer (mCRPC)
    • Oogheelkunde
    • Reumatologie
  • Congressen en evenementen
    • Cardiologie
      • BSC
      • ESC
    • Dermatologie
      • EADV
      • Sharing is Caring
    • Hematologie
      • ASH
      • EHA
      • ESH
    • Neurologie
      • CMSC
      • EAN
      • ECTRIMS
    • Oncologie
      • ASCO
      • EBCC
      • ESMO
      • SABCS
    • Reumatologie
      • Sharing is Caring
  • Contact

Popular Search

  • improved
  • improving
  • aimovig
  • migration
  • migraine

Recent News

RLTech and Nurse Academy
Page protected by password
Netelroos - Doe the test
Search
  • Cosentyx® Reimbursement form Initiation B (French)

      Download French document    
  • Cosentyx® Reimbursement form Initiation B (Dutch)

      Download Dutch document     #edit-submit{diplay:none;}
  • Cosentyx® Letter for the General Practitioner (French)

      Download French document     To receive by post, click on the "Add to card" button below
  • Cosentyx® Letter for the General Practitioner (Dutch)

      Download Dutch document     To receive by post, click on the "Add to card" button below
  • Cosentyx® Letter for the consulting physician in case of treatment switch (French)

      Download French document     To receive by post, click on the "Add to card" button below
  • Cosentyx® Letter for the consulting physician in case of treatment switch (Dutch)

      Download Dutch document     To receive by post, click on the "Add to card" button below
  • Indications - Cosentyx PsA

    Cosentyx (generic name: secukinumab) is a medication used to treat several autoimmune conditions. Here are the key indications for Cosentyx:

    1. Plaque Psoriasis:

    For adults with moderate to severe...

    Twitter Linkedin Facebook Pinterest Google plus
  • Efficacy - Cosentyx PsA

    Twitter Linkedin Facebook Pinterest Google plus
  • Safety profile - Cosentyx PsA

    Twitter Linkedin Facebook Pinterest Google plus
  • Dosing - Consentyx PsA

    Twitter Linkedin Facebook Pinterest Google plus
  • < vorige
page 

Pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
 of  13
  • volgende >

Filter by area of interest:

Volg Novartis

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube
Sitemap
Cookie Settings
©2025 Novartis België en Luxemburg
  • Gebruiksvoorwaarden
  • Over cookies
Deze website is bestemd voor zorgverleners in België en Luxemburg